developing countries, Vantictumab is being kept more affordable to ensure public
health. This will be done through cheaper manufacturing which allows for lower
labor costs and will ensure that our pharmaceutical company do not drastically
reduce the profits.
We will broaden our initiative by attracting several public and private
partners like WHO, UNICEF, The Global fund by United Nations and private
foundations like Bill and Melinda Gates foundation to further offer direct
support to countries by providing funds in order to help governments so they
can help their people in need.